Roche Holding AG (TSX:ROG)
Canada · Delayed Price · Currency is CAD 23.46
-0.55 (-2.29%)
At close: Mar 20, 2026
Revenue
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Roche Pharmaceuticals Revenue | 44.79B | 43.30B | ||||||||||||
Roche Pharmaceuticals Revenue Growth | 3.44% | 6.85% | ||||||||||||
Chugai Revenue | 2.88B | 2.87B | ||||||||||||
Chugai Revenue Growth | 0.28% | -23.26% | ||||||||||||
Pharmaceuticals Revenue | 47.67B | 46.17B | ||||||||||||
Pharmaceuticals Revenue Growth | 3.24% | 4.31% | ||||||||||||
Diagnostics Revenue | 13.85B | 14.32B | ||||||||||||
Diagnostics Revenue Growth | -3.33% | -0.88% | ||||||||||||
Revenue (Other) | 1.84B | 1.90B | ||||||||||||
Revenue (Total) | 63.36B | 62.40B | ||||||||||||
Revenue (Total) Growth | 1.54% | 3.23% |
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Switzerland Revenue | 819.00M | 747.00M | ||||||||||||
Switzerland Revenue Growth | 9.64% | 10.02% | ||||||||||||
Germany Revenue | 3.12B | 2.93B | ||||||||||||
Germany Revenue Growth | 6.63% | 2.13% | ||||||||||||
Rest of Europe Revenue | 10.86B | 10.29B | ||||||||||||
Rest of Europe Revenue Growth | 5.53% | 6.06% | ||||||||||||
Europe Revenue | 14.80B | 13.97B | ||||||||||||
Europe Revenue Growth | 5.98% | 5.41% | ||||||||||||
United States Revenue | 29.50B | 28.90B | ||||||||||||
United States Revenue Growth | 2.08% | 6.32% | ||||||||||||
Rest of North America Revenue | 972.00M | 889.00M | ||||||||||||
Rest of North America Revenue Growth | 9.34% | 6.21% | ||||||||||||
North America Revenue | 30.48B | 29.79B | ||||||||||||
North America Revenue Growth | 2.30% | 6.32% | ||||||||||||
Latin America Revenue | 3.25B | 3.25B | ||||||||||||
Latin America Revenue Growth | -0.12% | 9.36% | ||||||||||||
Japan Revenue | 3.04B | 3.15B | ||||||||||||
Japan Revenue Growth | -3.77% | -27.89% | ||||||||||||
Rest of Asia Revenue | 8.60B | 9.09B | ||||||||||||
Rest of Asia Revenue Growth | -5.35% | 2.19% | ||||||||||||
Asia Revenue | 11.63B | 12.24B | ||||||||||||
Asia Revenue Growth | -4.94% | -7.73% | ||||||||||||
Africa, Australia and Oceania Revenue | 1.36B | 1.25B | ||||||||||||
Africa, Australia and Oceania Revenue Growth | 8.80% | 3.14% | ||||||||||||
Revenue (Total) | 63.36B | 62.40B | ||||||||||||
Revenue (Total) Growth | 1.54% | 3.23% |
EBIT
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Roche Pharmaceuticals Operating Profit | 18.64B | 12.34B | ||||||||||||
Roche Pharmaceuticals Operating Profit Growth | 51.12% | -15.77% | ||||||||||||
Chugai Operating Profit | 3.23B | 3.21B | ||||||||||||
Chugai Operating Profit Growth | 0.40% | 10.19% | ||||||||||||
Pharmaceuticals Operating Profit | 21.67B | 15.59B | ||||||||||||
Pharmaceuticals Operating Profit Growth | 39.00% | -12.97% | ||||||||||||
Diagnostics Operating Profit | 1.07B | 1.95B | ||||||||||||
Diagnostics Operating Profit Growth | -45.02% | 39.80% | ||||||||||||
Corporate Operating Profit | -4.26B | -4.12B | ||||||||||||
Operating Income (Total) | 18.48B | 13.42B | ||||||||||||
Operating Income (Total) Growth | 37.71% | -12.85% |
Capital Expenditures
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Roche Pharmaceuticals Capital Expenditures | 6.68B | 6.00B | ||||||||||||
Roche Pharmaceuticals Capital Expenditures Growth | 11.19% | -30.87% | ||||||||||||
Chugai Capital Expenditures | 595.00M | 350.00M | ||||||||||||
Chugai Capital Expenditures Growth | 70.00% | -28.57% | ||||||||||||
Pharmaceuticals Capital Expenditures | 7.27B | 6.35B | ||||||||||||
Pharmaceuticals Capital Expenditures Growth | 14.43% | -30.75% | ||||||||||||
Diagnostics Capital Expenditures | 2.20B | 2.44B | ||||||||||||
Diagnostics Capital Expenditures Growth | -9.81% | -7.83% | ||||||||||||
Corporate Capital Expenditures | 53.00M | 78.00M | ||||||||||||
Corporate Capital Expenditures Growth | -32.05% | -11.36% |
Updated Dec 31, 2025. Data Source: Fiscal.ai.